IP Verse

Microporous Zirconium Silicate For The Treatment Of Hyperkalemia - EP2673237B1

PatentPatent Analysis

EP2673237

ZS PHARMA
Application Number
EP12744254A
Filing Date
Feb 10, 2012
Status
Granted And Under Opposition
Oct 5, 2018
Grant Date
Nov 7, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2981272B1

Bibliography

The patent EP2673237B1 was granted to ZS Pharma on Nov 7, 2018 following the initial filing on Feb 10, 2012 under the application number EP12744254A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GALENICUM HEALTH SLUAug 6, 2019ADMISSIBLE
SANDOZAug 6, 2019ADMISSIBLE
TEVA PHARMACEUTICALSAug 5, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents